🚨 The Trump Mention Effect Strikes Again

⠀

Two new companies were directly named in the recent speech: $Eli Lilly(LLY.US) Eli Lilly and $Nokia Oyj(NOK.US) Nokia.

⠀

Remember Micron and Dell? When Trump publicly names a company, it often signals a direction.

⠀

⚡ Political Attention Translates into Market Pricing

⠀

After being mentioned by Trump, the market began to re-evaluate Micron's strategic position in U.S. chip manufacturing. The same happened with Dell—once in the political spotlight, capital starts calculating how much benefit this company can reap from localized manufacturing and supply chain shifts.

⠀

Now it's Eli Lilly and Nokia's turn.

⠀

💊 $Eli Lilly(LLY.US) Eli Lilly's Domestic Manufacturing Strategy

⠀

Localizing production capacity for obesity drugs and biopharmaceuticals directly ties into the story of U.S. manufacturing reshoring. If Lilly can capture the manufacturing end of this track, the policy dividends could far exceed expectations.

⠀

📡 $Nokia Oyj(NOK.US) Nokia's Telecom Infrastructure Positioning

⠀

We previously mentioned Nokia's work on network operating systems and localized manufacturing. Now being named by Trump means this company has entered the view of policymakers—Pennsylvania expansion, localized photonic chip production, these may all receive more policy support.

Trump's naming is not aimless. It's usually underpinned by several logical threads: supply chain security, manufacturing reshoring, and geopolitical competition. The mentioned companies often signify they are about to become targets of policy support.

⠀

This is the real catalyst. Not the product itself, but political pricing.